Press Releases

WESTFORD, Mass., Nov. 8, 2019 /PRNewswire/ -- National Pressure Ulcer Advisory Panel (NPUAP) is pleased to announce that it has changed its name to the National Pressure Injury Advisory Panel (NPIAP).  The new name reflects the future direction of the organization and a reaffirming of our commitment to adopt the internationally preferred term, pressure injury,

SIMI VALLEY, Calif., Nov. 8, 2019 /PRNewswire/ -- EazyHold is one of 6 in the running to receive the 2019 first-ever Amazons Woman-Owned Small Business of the Year Award.An A

LAUSANNE, Switzerland, Nov. 8, 2019 /PRNewswire/ -- Debiopharm (www.debiopharm.com), a Swiss biopharmaceutical company, announced today it has been

Combined company joins two leading brands in cancer diagnostics, Cologuard® and Oncotype DX®, providing a strong platform for continued growth MADISON, Wis., Nov. 8, 2019 /PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS) today announced that it has completed its

LYNBROOK, N.Y., Nov. 8, 2019 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first in class collagenase-based product marketed as XIAFLEX® in the U.S. and Xiapex® in Europe, today announced its financial results for the third

ROCKLAND, Mass. and NEW YORK, Nov. 8, 2019 /PRNewswire/ -- EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the US and Canada, and Pfizer Inc. (NYSE: PFE) today announced topline results of the Phase III JAVELIN Gastric 100 study evaluati

ROUND ROCK, Texas, Nov. 8, 2019 /PRNewswire/ -- ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF), a global, research-driven pharmaceutical company that focuses on the prevention, diagnosis and treatment of allergies, announced new Phase 3 data today on its sublingual allergy immunotherapy (SLIT) portfolio, including efficacy and safety findings from the largest all

CRANFORD, N.J., Nov. 8, 2019 /PRNewswire/ -- Citius Pharmaceuticals, Inc. (NASDAQ:  CTXR) ("Citius" or the "Company"), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, today announced that the Company has issued its October 2019 Corporate Update Letter.  The Letter highlights the progress of the Com

WALTHAM, Mass., Nov. 8, 2019 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its board of directors declared a quarterly cash dividend of $0.19 per share.  The dividend will be paid on January 15, 2020, to shareholders of record as of D

NETANYA, Israel, Nov. 8, 2019 /PRNewswire/ -- Theranica Bio-Electronics Ltd., a bio-medical technology company developing advanced electroceuticals for migraine and other pain disorders, announced today that the American Headache Society published an article in its peer-reviewed journal,